Vimarsana
Biggest News Aggregation in the World

Lichen Planus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lichen Planus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lichen Planus Today - Breaking & Trending Today

Jeffrey Cohen, MD: Understanding Pathways, Treatments for Lichenoid Dermatoses - Vimarsana News

Jeffrey Cohen, MD: Understanding Pathways, Treatments for Lichenoid Dermatoses

This segment of Cohen’s interview from AAD covered the other talk given by Cohen titled ‘Knowing Lichenoid Dermatoses: Common Pathways and Treatments.’

Learn What Your Tongue Says About Your General Health - Vimarsana News

Learn What Your Tongue Says About Your General Health

The changes in the tongue's normal appearance are linked to the function of various vital organs, which provide clues about what is going on within our overall health.

Dr Mona Shahriari Talks Unique Challenges in Treating Psoriasis in Patients With Skin of Color - Vimarsana News

Dr Mona Shahriari Talks Unique Challenges in Treating Psoriasis in Patients With Skin of Color

Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology, discusses unique challenges dermatologists face when treating patients with skin of color, who may present differently from White patients.

Source: ajmc.com
Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-310 for Oral Lichen Planus - Vimarsana News

Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-310 for Oral Lichen Planus

/PRNewswire/ -- Lipella Pharmaceuticals Inc. (Nasdaq: "LIPO") ("Lipella," "our, "us" or the "Company"), a clinical-stage biotechnology company addressing...

These Adverse Events Linked to Improved Cancer Prognosis - Vimarsana News

These Adverse Events Linked to Improved Cancer Prognosis

Cutaneous immune-related adverse events are associated with a better prognosis among patients with cancer who receive immune checkpoint inhibitors, new research suggests.